SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Business
Astria Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
August 9, 2022
 · 
10 min read
Drug Development
Astria Therapeutics Announces Initiation of Phase 1a Trial of STAR-0215, a Monoclonal Antibody Inhibitor of Plasma Kallikrein for Treatment of Hereditary Angioedema
August 4, 2022
 · 
6 min read
Genetown
Astria Therapeutics to Present at Upcoming Wedbush PacGrow Healthcare Conference 2022
August 3, 2022
 · 
1 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 02, 2022
August 2, 2022
 · 
2 min read
FDA
Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0215, a Monoclonal Antibody Inhibitor of Plasma Kallikrein for Treatment of Hereditary Angioedema
July 28, 2022
 · 
5 min read
Business
Astria Therapeutics Names Chris Morabito Chief Medical Officer
July 15, 2022
 · 
5 min read
Genetown
Astria Therapeutics to Participate in Virtual Fireside Chat at Upcoming H.C. Wainwright 1st Annual Hereditary Angioedema Conference
July 14, 2022
 · 
1 min read
Drug Development
Astria Therapeutics Presents New Preclinical Data Showing Differentiated Profile of STAR-0215, in Development for Treatment of Hereditary Angioedema
July 5, 2022
 · 
5 min read
Drug Development
Astria Therapeutics to Present New Preclinical STAR-0215 Data at the European Academy of Allergy and Clinical Immunology 2022 Hybrid Congress
June 23, 2022
 · 
5 min read
Genetown
Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference
June 3, 2022
 · 
1 min read
Load More